/AMGEN%20Inc_%20logo%20on%20website-by%20Jimmy%20Tudeschi%20via%20Shutterstock.jpg)
Based in Thousand Oaks, California, Amgen Inc. (AMGN) is a global leader in biotechnology, pioneering advancements in human therapeutics. With a market cap of $178.71 billion, Amgen is renowned for its innovative portfolio that enhances patient care through cutting-edge biologics and biosimilars. The company is set to announce its fiscal Q2 earnings results after the market closes on Tuesday, Aug. 6.
Ahead of the event, analysts expect AMGN to report a profit of $4.87 per share, down 2.6% from $5 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.